The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours
Top Cited Papers
- 19 May 2005
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 435 (7040) , 360-364
- https://doi.org/10.1038/nature03595
Abstract
The phenotype of Ter testicular germ cell tumour susceptibility gene was first described more than 30 years ago, but it has taken until now for the identity of the gene to be discovered. Ter is a mutation inducing a termination codon on the mouse version of the dead end gene, known from zebrafish embryos. It encodes a protein with an RNA recognition motif, thus implicating RNA biology in testicular tumour development. In mice, the Ter mutation causes primordial germ cell (PGC) loss in all genetic backgrounds1. Ter is also a potent modifier of spontaneous testicular germ cell tumour (TGCT) susceptibility in the 129 family of inbred strains, and markedly increases TGCT incidence in 129-Ter/Ter males2,3,4. In 129-Ter/Ter mice, some of the remaining PGCs transform into undifferentiated pluripotent embryonal carcinoma cells2,3,4,5,6, and after birth differentiate into various cells and tissues that compose TGCTs. Here, we report the positional cloning of Ter, revealing a point mutation that introduces a termination codon in the mouse orthologue (Dnd1) of the zebrafish dead end (dnd) gene. PGC deficiency is corrected both with bacterial artificial chromosomes that contain Dnd1 and with a Dnd1-encoding transgene. Dnd1 is expressed in fetal gonads during the critical period when TGCTs originate. DND1 has an RNA recognition motif and is most similar to the apobec complementation factor, a component of the cytidine to uridine RNA-editing complex. These results suggest that Ter may adversely affect essential aspects of RNA biology during PGC development. DND1 is the first protein known to have an RNA recognition motif directly implicated as a heritable cause of spontaneous tumorigenesis. TGCT development in the 129-Ter mouse strain models paediatric TGCT in humans. This work will have important implications for our understanding of the genetic control of TGCT pathogenesis and PGC biology.Keywords
This publication has 33 references indexed in Scilit:
- Mechanisms of gene silencing by double-stranded RNANature, 2004
- RBMY, a male germ cell-specific RNA-binding protein, activated in human liver cancers and transforms rodent fibroblastsOncogene, 2004
- A Noncoding RNA Is Required for the Repression of RNApolII-Dependent Transcription in Primordial Germ CellsCurrent Biology, 2004
- Meiotic germ cells antagonize mesonephric cell migration and testis cord formation in mouse gonadsDevelopment, 2003
- A conserved RNA-binding protein controls germline stem cells in Caenorhabditis elegansNature, 2002
- Overexpression of an mRNA-binding protein in human colorectal cancerOncogene, 2001
- DEF-3(g16/NY-LU-12), an RNA binding protein from the 3p21.3 homozygous deletion region in SCLCOncogene, 1999
- Homologous recombination based modification in Esherichia coli and germline transmission in transgenic mice of a bacterial artificial chromsomeNature Biotechnology, 1997
- The ter mutation first causes primordial germ cell deficiency in ter/ter mouse embryos at 8 days of gestationDevelopment, Growth & Differentiation, 1995
- A mutation in the Ter gene causing increased susceptibility to testicular teratomas maps to mouse chromosome 18Nature Genetics, 1994